Invited reviews

Invited reviews

1. Balfour-Lynn IM. Why do viruses make infants wheeze? Arch Dis Child 1996;74:251-59.

Print paper.

2. Balfour-Lynn IM, Dinwiddie R. Role of corticosteroids in cystic fibrosis lung disease. J Roy Soc Med 1996;89 (suppl 27):8-13.

Print paper.

3. Dinwiddie R, Balfour-Lynn IM. Anti-inflammatory therapy in cystic fibrosis. Paed Allergy Immunol 1996;7 (suppl 9):70-73

4. Balfour-Lynn IM. Inhaled corticosteroids in cystic fibrosis – in favour of their use. Pediatr Pulmonol 1998;Suppl 17:169-71.

Print paper (S18.1).

5. Balfour-Lynn IM. Difficult asthma – beyond the guidelines. Arch Dis Child 1999;80:201-6.

Print paper

6. Balfour-Lynn IM. The protease – antiprotease battle in the cystic fibrosis lung. J Roy Soc Med 1999;92(suppl 37):23-30.

Print paper

7. Dinwiddie R, Madge S, Prasad SA, Balfour-Lynn IM. Oxygen therapy for cystic fibrosis. J Roy Soc Med 1999;92(suppl 37):19-22.

Print paper

8. Suri R, Balfour-Lynn IM. Effective cystic fibrosis management in the young. Prescriber 2000;11:97-102.

9. Aurora P, Balfour-Lynn IM. Lung transplant and end of life issues in cystic fibrosis. Paed Resp Rev 2000;1:114-120.

Print paper

10. Payne DNR, Balfour-Lynn IM. Difficult asthma in children: a practical approach. J Asthma 2001;38:189-203.

Print paper

11. Jaffe A, Balfour-Lynn IM. Treatment of severe small airways disease in children with cystic fibrosis: alternatives to corticosteroids. Paediatric Drugs 2002;4:381-389.

Print paper

12. Balfour-Lynn IM, Elborn S. “CF asthma”: what is it and what do we do about it? Thorax 2002;57:742-748.

Print paper

13. Balfour-Lynn IM. Asthma in CF: corticosteroids. Pediatr Pulmonol 2002; Suppl 24:101-102

Print paper (S3.4).

14. Balfour-Lynn IM. Inhaled steroids in cystic fibrosis. Pediatr Pulmonol 2002; Suppl 24:166-167.

Print paper (S16.2).

15. Balfour-Lynn IM, Spencer H. Bronchoscopy – how and when? Paed Resp Rev 2002;3:255-264.

Print paper

16. Balfour-Lynn IM. Asthma in CF. J R Soc Med 2003;96 Suppl 43:30-4.

Print paper

17. Suri R, Balfour-Lynn IM. When to do a flexible bronchoscopy. Curr Paediatr 2004;14:306-12.

Print paper

18. Balfour-Lynn IM, Primhak RA, Shaw BNJ. Home oxygen for children. Who, how and when? Thorax 2005;60:76-81.

Print paper

19. Balfour-Lynn IM. Some consensus but little evidence – guidelines on management of pleural infection in children. Thorax 2005;60:94-96.

Print paper

20. Jaffe A, Balfour-Lynn IM. State of the Art: Management of empyema. Pediatr Pulmonol 2005;40:148-156.

Print paper

21. Balfour-Lynn IM, Lees B, Hall P, Phillips G, Khan M, Flather M, Elborn S, CF WISE Investigators. CF WISE –Multicentre randomised controlled trial of withdrawal of inhaled corticosteroids. Pediatr Pulmonol 2005;Suppl 28:123-4.

22. Balfour-Lynn IM. Review of Journal of Cystic Fibrosis, Times Higher Educational Supplement, Nov 24th 2006.

23. Balfour-Lynn IM. Anti-inflammatory approaches to cystic fibrosis airways disease. Curr Opin Pulm Med 2007;13:522-8.

Print paper

24. Bossley C, Balfour-Lynn IM. Is this baby fit to fly? Hypoxia in aeroplanes. Early Hum Dev 2007;83:755-9.

Print paper

25. Balfour-Lynn IM. Newborn screening for cystic fibrosis: evidence for benefit. Arch Dis Child 2008;93:7-10.

Print paper

26. Bossley C, Balfour-Lynn IM. Taking young children on aeroplanes: what are the risks? Arch Dis Child 2008;93:528-33.

Print paper

27. Balfour-Lynn IM. Cystic fibrosis papers of the year 2007. J R Soc Med. 2008;101 Suppl 1:S10-4.

Print paper

28. Balfour-Lynn IM. Domiciliary oxygen for children. Pediatr Clin North Am 2009;56:275-96.

Print paper

29. Balfour-Lynn IM. Cystic fibrosis papers of the year 2008. J R Soc Med. 2009:102 Suppl 1:29-35.

Print paper

30. Thia LP, Balfour Lynn IM. Diagnosing allergic bronchopulmonary aspergillosis in children with cystic fibrosis. Paediatr Respir Rev 2009;10:37-42.

Print paper

31. Balfour-Lynn IM. Cystic fibrosis papers of the year 2009. J R Soc Med 2010;103 Suppl 1:S6-14.

Print paper

32. Ives A, Daubeney PEF, Balfour-Lynn IM. Recurrent chest pain in the well child. Arch Dis Child 2010;95:649-54

Print paper

33. Balfour-Lynn IM. Long term home oxygen: a UK perspective. Jornal Pediatria (Rio). 2011;87:1-3.

Print paper

34. Balfour-Lynn IM, Adams A. The role of flexible bronchoscopy. Paed & Child Health. 2011;21:219-23.

Print paper

35. Luisetti M, Balfour-Lynn IM, Johnson SR, Miravitlles M, Strange C, Trapnell BC, van Bronswijk H, Vogelmeier C. Perspectives for improving the evaluation and access of therapies for rare lung diseases in Europe. Respir Med 2012;106:759-68.

Print paper

36. Pabary R, Balfour-Lynn IM. Management of complicated pneumonia in children. Breathe 2013;9:210-22.

Print paper

37. Balfour-Lynn IM. At last, Burholderia spp. is one of the inclusion criteria – a negative (but published) randomised controlled trial. J Cystic Fibros. 2014. In press.

Print paper

38. Balfour-Lynn IM. Personalized medicine in cystic fibrosis is unaffordable. Paed Resp Rev 2014;15 Suppl 1:2-5.

Print paper

39. Balfour-Lynn IM, Rigby ML. Tachypnoea in a well baby: what to do next? Arch Dis Child 2015 Mar 9. pii: archdischild-2014-306692. doi: 10.1136/archdischild-2014-306692. [Epub ahead of print].

Print paper

40. Turnbull A, Balfour-Lynn IM. Recent advances in paediatric respiratory medicine. Arch Dis Child 2016;101:193-7.

Print paper

41. Grigg J, Balfour-Lynn IM, Everard M, Hall G, Karadag B, Priftis K, Roehr CC, Rottier BL, Midulla F. Key paediatric messages from the 2016 European Respiratory Society International Congress. ERJ Open Res 2017;3.pii: 00127-2016. doi: 10.1183/23120541.00127-2016.

Print paper

42. Balfour-Lynn IM. Hypoxic Challenge Test for airflight in children with respiratory disease. Paediatr Respir Rev 2017;21:62-64.

Print paper

43. Balfour-Lynn IM. Medicolegal issues for the respiratory paediatrician. Paediatr Respir Rev. 2017 Oct 12. pii: S1526-0542(17)30091-X. doi:10.1016/j.prrv.2017.09.001. [Epub ahead of print].

Print paper

44. Balfour-Lynn IM. Milk, Mucus and myths. Arch Dis Child 2019;104:91-3.

Print paper

45. Balfour-Lynn IM. Clinical papers of the year 2018 – Cystic fibrosis. Paediatr Respir Rev. 2019 Apr 5. pii: S1526-0542(19)30034-X. doi:10.1016/j.prrv.2019.03.008. [Epub ahead of print].

Print paper

46. Carroll WD, Strenger V, Eber E, Porcaro F, Cutrera R, Fitzgerald DA, Balfour-Lynn IM. European and United Kingdom COVID-19 pandemic experience: The same but different. Paediatr Respir Rev 2020;35:50-56.

Print paper

47. Balfour-Lynn IM, King JA. CFTR modulator therapies – Effect on life expectancy in people with cystic fibrosis. Paediatr Respir Rev. 2020 May 26:S1526-0542(20)30081-6. doi: 10.1016/j.prrv.2020.05.002. Epub ahead of print.

Print paper

48. Balfour-Lynn IM. Environmental risks of Pseudomonas aeruginosa – what to advise patients and parents. J Cyst Fibrosis 2020;20:17-24.

Print paper

49. Richardson CH, Orr NJ, Ollosson SL, Irving SJ, Balfour-Lynn IM, Carr SB. Initiating home spirometry for children during the COVID-19 pandemic – A practical guide. Paediatr Respir Rev. 2021 Feb 19:S1526-0542(21)00004-X. doi: 10.1016/j.prrv.2021.02.001. Epub ahead of print..

Print paper

50. Balfour-Lynn LP, Balfour-Lynn RE, Balfour-Lynn IM. Three generations of paediatric training. Arch Dis Child. 2021 May 20:archdischild-2021-322160. doi: 10.1136/archdischild-2021-322160. Epub ahead of print.

Print paper

51. Balfour-Lynn IM, Puckey M, Simmonds NJ, Davies JC. Revisiting a diagnosis of cystic fibrosis – Uncertainties and considerations. Paediatr Respir Rev. 2021 Dec 8:S1526-0542(21)00110-X. doi: 10.1016/j.prrv.2021.11.002. Epub ahead of print.

Print paper

© Dr. Ian Balfour-Lynn
Powered by LondonWeb
Designed by CrestanaDS